| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| SLDB | Exit | SOLID BIOSCIENCES INC | $0 | – | -50,000 | -100.0% | -0.25% | – |
| MRNS | Exit | MARINUS PHARMACEUTICALS INC | $0 | – | -100,000 | -100.0% | -0.25% | – |
| KTWO | Exit | K2M GROUP HLDGS INC | $0 | – | -25,000 | -100.0% | -0.31% | – |
| OMED | Exit | ONCOMED PHARMACEUTICALS INC | $0 | – | -150,000 | -100.0% | -0.31% | – |
| SCYX | Exit | SCYNEXIS INC | $0 | – | -400,000 | -100.0% | -0.35% | – |
| AFMD | Exit | AFFIMED N V | $0 | – | -300,000 | -100.0% | -0.36% | – |
| EXEL | Exit | EXELIXIS INC | $0 | – | -30,000 | -100.0% | -0.44% | – |
| ADMS | Exit | ADAMAS PHARMACEUTICALS INC | $0 | – | -30,000 | -100.0% | -0.47% | – |
| ASMB | Exit | ASSEMBLY BIOSCIENCES INC | $0 | – | -15,000 | -100.0% | -0.48% | – |
| DERM | Exit | DERMIRA INC | $0 | – | -100,000 | -100.0% | -0.53% | – |
| SPPI | Exit | SPECTRUM PHARMACEUTICALS INC | $0 | – | -50,000 | -100.0% | -0.53% | – |
| SGEN | Exit | SEATTLE GENETICS INC | $0 | – | -17,500 | -100.0% | -0.60% | – |
| KURA | Exit | KURA ONCOLOGY INC | $0 | – | -50,000 | -100.0% | -0.62% | – |
| XNCR | Exit | XENCOR INC | $0 | – | -35,000 | -100.0% | -0.69% | – |
| CERN | Exit | CERNER CORP | $0 | – | -20,000 | -100.0% | -0.76% | – |
| ADVM | Exit | ADVERUM BIOTECHNOLOGIES INC | $0 | – | -200,000 | -100.0% | -0.76% | – |
| CTLT | Exit | CATALENT INC | $0 | – | -30,000 | -100.0% | -0.81% | – |
| INCY | Exit | INCYTE CORP | $0 | – | -15,000 | -100.0% | -0.82% | – |
| CORI | Exit | CORIUM INTL INC | $0 | – | -110,000 | -100.0% | -0.83% | – |
| AKAOQ | Exit | ACHAOGEN INC | $0 | – | -100,000 | -100.0% | -0.85% | – |
| VYGR | Exit | VOYAGER THERAPEUTICS INC | $0 | – | -70,000 | -100.0% | -0.86% | – |
| MRUS | Exit | MERUS N V | $0 | – | -75,000 | -100.0% | -0.91% | – |
| ARWR | Exit | ARROWHEAD PHARMACEUTICALS IN | $0 | – | -200,000 | -100.0% | -0.95% | – |
| VKTX | Exit | VIKING THERAPEUTICS INC | $0 | – | -375,000 | -100.0% | -1.08% | – |
| KPTI | Exit | KARYOPHARM THERAPEUTICS INC | $0 | – | -125,000 | -100.0% | -1.10% | – |
| MRTX | Exit | MIRATI THERAPEUTICS INC | $0 | – | -55,000 | -100.0% | -1.11% | – |
| IOVA | Exit | IOVANCE BIOTHERAPEUTICS INC | $0 | – | -100,000 | -100.0% | -1.11% | – |
| CTMX | Exit | CYTOMX THERAPEUTICS INC | $0 | – | -65,000 | -100.0% | -1.22% | – |
| MYOK | Exit | MYOKARDIA INC | $0 | – | -40,000 | -100.0% | -1.28% | – |
| DPLO | Exit | DIPLOMAT PHARMACY INC | $0 | – | -100,000 | -100.0% | -1.33% | – |
| SRRA | Exit | SIERRA ONCOLOGY INC | $0 | – | -1,000,000 | -100.0% | -1.36% | – |
| Exit | SPDR SERIES TRUSTput | $0 | – | -25,000 | -100.0% | -1.44% | – | |
| ARMO | Exit | ARMO BIOSCIENCES INC | $0 | – | -60,000 | -100.0% | -1.48% | – |
| MDCO | Exit | MEDICINES CO | $0 | – | -70,000 | -100.0% | -1.52% | – |
| GSK | Exit | GLAXOSMITHKLINE PLCsponsored adr | $0 | – | -60,000 | -100.0% | -1.54% | – |
| RCKT | Exit | ROCKET PHARMACEUTICALS INC | $0 | – | -125,000 | -100.0% | -1.54% | – |
| SGMO | Exit | SANGAMO THERAPEUTICS INC | $0 | – | -125,000 | -100.0% | -1.56% | – |
| ZSAN | Exit | ZOSANO PHARMA CORP | $0 | – | -500,000 | -100.0% | -1.66% | – |
| TSRO | Exit | TESARO INC | $0 | – | -45,000 | -100.0% | -1.69% | – |
| CBIO | Exit | CATALYST BIOSCIENCES INC | $0 | – | -100,000 | -100.0% | -1.70% | – |
| DXCM | Exit | DEXCOM INC | $0 | – | -35,000 | -100.0% | -1.71% | – |
| ADMA | Exit | ADMA BIOLOGICS INC | $0 | – | -600,000 | -100.0% | -1.82% | – |
| LH | Exit | LABORATORY CORP AMER HLDGS | $0 | – | -17,500 | -100.0% | -1.86% | – |
| ABT | Exit | ABBOTT LABS | $0 | – | -50,000 | -100.0% | -1.97% | – |
| RARE | Exit | ULTRAGENYX PHARMACEUTICAL IN | $0 | – | -60,000 | -100.0% | -2.01% | – |
| ALXN | Exit | ALEXION PHARMACEUTICALS INC | $0 | – | -27,500 | -100.0% | -2.02% | – |
| BMY | Exit | BRISTOL MYERS SQUIBB CO | $0 | – | -50,000 | -100.0% | -2.08% | – |
| CNC | Exit | CENTENE CORP DEL | $0 | – | -30,000 | -100.0% | -2.11% | – |
| MYL | Exit | MYLAN N V | $0 | – | -80,000 | -100.0% | -2.17% | – |
| CI | Exit | CIGNA CORPORATION | $0 | – | -20,000 | -100.0% | -2.21% | – |
| ANAB | Exit | ANAPTYSBIO INC | $0 | – | -32,500 | -100.0% | -2.22% | – |
| Exit | ESPERION THERAPEUTICS INC NEput | $0 | – | -50,000 | -100.0% | -2.38% | – | |
| CLVS | Exit | CLOVIS ONCOLOGY INC | $0 | – | -70,000 | -100.0% | -2.43% | – |
| SHPG | Exit | SHIRE PLCsponsored adr | $0 | – | -25,000 | -100.0% | -2.46% | – |
| ARNA | Exit | ARENA PHARMACEUTICALS INC | $0 | – | -100,000 | -100.0% | -2.60% | – |
| MRK | Exit | MERCK & CO INC | $0 | – | -80,000 | -100.0% | -2.87% | – |
| BIIB | Exit | BIOGEN INC | $0 | – | -17,500 | -100.0% | -3.15% | – |
| HUM | Exit | HUMANA INC | $0 | – | -20,000 | -100.0% | -3.54% | – |
| GBT | Exit | GLOBAL BLOOD THERAPEUTICS IN | $0 | – | -115,000 | -100.0% | -3.65% | – |
| IMMU | Exit | IMMUNOMEDICS INC | $0 | – | -400,000 | -100.0% | -3.84% | – |
| ESPR | Exit | ESPERION THERAPEUTICS INC NE | $0 | – | -100,000 | -100.0% | -4.76% | – |
| Exit | SPDR S&P 500 ETF TRput | $0 | – | -50,000 | -100.0% | -8.66% | – |
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| BIOGEN INC | 17 | Q1 2018 | 7.5% |
| ULTRAGENYX PHARMACEUTICAL IN | 17 | Q1 2018 | 6.7% |
| MERCK & CO INC NEW | 16 | Q1 2018 | 5.4% |
| CELGENE CORP | 15 | Q4 2017 | 7.9% |
| AERIE PHARMACEUTICALS INC | 15 | Q4 2017 | 3.3% |
| GILEAD SCIENCES INC | 14 | Q1 2017 | 6.7% |
| ESPERION THERAPEUTICS INC NE | 14 | Q1 2018 | 7.8% |
| SUPERNUS PHARMACEUTICALS INC | 14 | Q4 2017 | 2.8% |
| DERMIRA INC | 14 | Q1 2018 | 2.7% |
| AMGEN INC | 13 | Q1 2017 | 6.5% |
View Iguana Healthcare Management, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2018-05-15 |
| 13F-HR | 2018-02-14 |
| 13F-HR/A | 2017-11-16 |
| 13F-HR | 2017-11-14 |
| 13F-HR | 2017-08-14 |
| 13F-HR | 2017-05-15 |
| 13F-HR | 2017-02-14 |
| 13F-HR/A | 2016-11-17 |
| 13F-HR | 2016-11-14 |
| 13F-HR/A | 2016-11-04 |
View Iguana Healthcare Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.